CARISMA THERAP (CARM)
(Delayed Data from NSDQ)
$1.13 USD
-0.06 (-5.04%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $1.15 +0.02 (1.77%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.37 | -16.22% |
Earnings Summary
For their last quarter, CARISMA THERAP (CARM) reported earnings of -$0.27 per share, beating the Zacks Consensus Estimate of $-0.36 per share. This reflects a positive earnings surprise of 25.00%. Look out for CARM's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.37 per share, reflecting a year-over-year increase of 30.19%.
Earnings History
Price & Consensus
Zacks News for CARM
Carisma Therapeutics Inc. (CARM) Reports Q2 Loss, Tops Revenue Estimates
CARM: What are Zacks experts saying now?
Zacks Private Portfolio Services